HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Kobayashi Selected Research

Glucose (Dextrose)

10/2023The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy.
3/20235-Oxoproline Enhances 4-Hydroxytamoxifen-induced Cytotoxicity by Increasing Oxidative Stress in MCF-7 Breast Cancer Cells.
1/2023Systemic depletion of WWP1 improves insulin sensitivity and lowers triglyceride content in the liver of obese mice.
1/2023Oral administration of linoleic acid immediately before glucose load ameliorates postprandial hyperglycemia.
6/2022Effects of a new 75 g glucose- and high fat-containing cookie meal test on postprandial glucose and triglyceride excursions in morbidly obese patients.
1/2022Long-term sensor-augmented pump therapy for neonatal diabetes mellitus: a case series.
1/2021Trehalose induces SQSTM1/p62 expression and enhances lysosomal activity and antioxidative capacity in adipocytes.
1/2020WWP1 knockout in mice exacerbates obesity-related phenotypes in white adipose tissue but improves whole-body glucose metabolism.
12/2019Hepatic Gluconeogenic Response to Single and Long-Term SGLT2 Inhibition in Lean/Obese Male Hepatic G6pc-Reporter Mice.
8/2019Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Kobayashi Research Topics

Disease

47Neoplasms (Cancer)
04/2024 - 03/2003
16Obesity
05/2024 - 03/2007
13Insulin Resistance
01/2023 - 07/2004
13Ischemia
01/2018 - 05/2008
12Breast Neoplasms (Breast Cancer)
03/2023 - 08/2007
12Vasculitis (Vasculitides)
11/2022 - 07/2004
11Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 09/2012
11Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2022 - 02/2010
10Diabetes Mellitus
10/2023 - 11/2009
9Glomerulonephritis
07/2022 - 09/2002
8Glucose Intolerance
05/2023 - 03/2007
8Infections
07/2022 - 02/2011
8Type 2 Diabetes Mellitus (MODY)
04/2022 - 01/2014
8Inflammation (Inflammations)
01/2022 - 12/2005
7Hyperglycemia
09/2023 - 01/2013
7Fabry Disease (Fabry's Disease)
08/2023 - 09/2009
6Hypoglycemia (Reactive Hypoglycemia)
10/2023 - 01/2013
6Diabetic Neuropathies (Diabetic Neuropathy)
03/2023 - 08/2015
6Septic Shock (Toxic Shock Syndrome)
01/2020 - 08/2008
6Choriocarcinoma
01/2019 - 02/2008
6Embryonal Rhabdomyosarcoma
04/2016 - 07/2005
5Pain (Aches)
01/2024 - 06/2010
5Hypoxia (Hypoxemia)
03/2023 - 05/2012
5Body Weight (Weight, Body)
08/2022 - 05/2006
5IGA Glomerulonephritis (IGA Nephropathy)
07/2022 - 07/2002
5Epilepsy (Aura)
06/2020 - 01/2017
5Carcinoma (Carcinomatosis)
01/2019 - 08/2004
4Necrosis
05/2024 - 10/2014
4Lung Neoplasms (Lung Cancer)
03/2024 - 10/2020
4Seizures (Absence Seizure)
10/2023 - 06/2020
4Chronic Kidney Failure (Chronic Renal Failure)
10/2023 - 03/2004
4Atrophy
10/2021 - 11/2018
4Mitochondrial Diseases (Mitochondrial Disease)
03/2021 - 01/2012
4Drug-Related Side Effects and Adverse Reactions
01/2021 - 12/2017
4Rhabdomyosarcoma
09/2020 - 07/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 02/2013
3Renal Insufficiency (Renal Failure)
10/2023 - 10/2008
3Parkinson Disease (Parkinson's Disease)
10/2023 - 10/2006
3Adenocarcinoma of Lung
01/2023 - 10/2013
3Hepatocellular Carcinoma (Hepatoma)
10/2022 - 04/2008
3Urinary Calculi (Urinary Calculus)
02/2022 - 01/2020
3Neoplasm Metastasis (Metastasis)
01/2022 - 07/2017
3Autoimmune Diseases (Autoimmune Disease)
12/2021 - 01/2019
3Acute Pain
12/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
12/2023 - 03/2006
20Glucose (Dextrose)FDA LinkGeneric
10/2023 - 03/2007
15Insulin (Novolin)FDA Link
09/2023 - 11/2008
15Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2022 - 07/2004
10Lactic Acid (Lactate)FDA LinkGeneric
01/2024 - 07/2005
9Cisplatin (Platino)FDA LinkGeneric
03/2024 - 09/2007
9CreatinineIBA
01/2020 - 10/2008
8NAD (NADH)IBA
03/2023 - 01/2013
7Glucagon (Glukagon)FDA Link
05/2023 - 09/2012
7EnzymesIBA
07/2019 - 08/2008
6Anticonvulsants (Antiepileptic Drugs)IBA
09/2023 - 10/2015
6GalactosidasesIBA
08/2023 - 01/2012
6Peroxidase (Myeloperoxidase)IBA
11/2022 - 07/2004
6Immunoglobulin A (IgA)IBA
07/2022 - 09/2002
6Polymyxin B (Aerosporin)FDA LinkGeneric
08/2016 - 08/2008
5LipidsIBA
05/2024 - 07/2019
5Uric Acid (Urate)IBA
12/2023 - 01/2012
5Blood Glucose (Blood Sugar)IBA
10/2023 - 01/2013
5Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2019
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 05/2008
5Messenger RNA (mRNA)IBA
01/2020 - 03/2002
5MicroRNAs (MicroRNA)IBA
01/2020 - 02/2011
4CholesterolIBA
05/2024 - 08/2007
4Small Interfering RNA (siRNA)IBA
04/2024 - 02/2011
4Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2010
4Triglycerides (Triacylglycerol)IBA
10/2023 - 03/2007
4Immunoglobulin G (IgG)IBA
01/2023 - 06/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 07/2004
4AdiponectinIBA
01/2022 - 07/2004
4LigandsIBA
01/2022 - 01/2015
4Docetaxel (Taxotere)FDA Link
12/2021 - 04/2012
4AntioxidantsIBA
10/2020 - 01/2011
4DNA (Deoxyribonucleic Acid)IBA
05/2020 - 06/2006
4Angiopoietin-1IBA
08/2016 - 12/2009
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2016 - 08/2007
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2014 - 06/2008
3C-Reactive ProteinIBA
04/2024 - 10/2016
3Diclofenac (SR 38)FDA LinkGeneric
01/2024 - 08/2021
3globotriaosylceramide (globotriosylceramide)IBA
08/2023 - 11/2017
3Immune Checkpoint InhibitorsIBA
01/2023 - 04/2019
3AutoantibodiesIBA
01/2023 - 07/2004
3SteroidsIBA
12/2022 - 01/2012
3mizoribineIBA
11/2022 - 07/2004
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2022 - 09/2002
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2012
3Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2017
3Multidrug Resistance-Associated ProteinsIBA
10/2021 - 08/2007
3AcidsIBA
03/2021 - 01/2012
3Antineoplastic Agents (Antineoplastics)IBA
10/2020 - 04/2012

Therapy/Procedure

26Therapeutics
05/2024 - 07/2004
7Drug Therapy (Chemotherapy)
11/2023 - 01/2012
6Renal Dialysis (Hemodialysis)
01/2022 - 01/2010
6Hemoperfusion
08/2016 - 08/2008
3Radiotherapy
11/2023 - 10/2016
3Caloric Restriction
10/2021 - 12/2018
3Glycemic Control
03/2021 - 01/2013